Literature DB >> 1762514

Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart.

W M Hu1, P C Choy, R Y Man.   

Abstract

Platelet-activating factor (PAF) is a potent phospholipid mediator with diverse in vivo and in vitro coronary vascular effects. In the present study, the coronary vascular responses to bolus injections of PAF were compared in rat hearts perfused under constant flow and under constant pressure. Low levels of PAF (1 pmol) produced vasodilatation only, while higher PAF concentrations (100 pmol) produced initial vasodilatation which was followed by a vasoconstriction under both experimental conditions. To determine species differences in PAF action, the effect of PAF was tested on perfused guinea pig hearts. Unlike in perfused rat hearts, only a dose-dependent vasoconstrictor response was observed in perfused guinea pig hearts following a bolus injection of 1 fmol to 10 pmol of PAF. The results from repeated injections of PAF indicated that depletion of vasoactive mediators induced by PAF or receptor desensitization may explain a failure of a second injection of PAF to initiate a vasoconstrictor response. After PAF injection, the coronary vascular response to leukotriene was not altered, indicating that the reduced vasoconstrictor effect of a second injection of PAF cannot be due to a reduced ability of the smooth muscle to constrict. The study demonstrates that similar coronary vascular responses to PAF are observed in perfused rat hearts under either constant flow rate or constant pressure and that some of the variable coronary vascular responses reported may be due to the difference between animal species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1762514     DOI: 10.1007/bf02535617

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  15 in total

Review 1.  Platelet activating factor: a biologically active phosphoglyceride.

Authors:  D J Hanahan
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

Review 2.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

3.  Platelet-activating factor and the release of a platelet-derived coronary artery vasodilator substance in the canine.

Authors:  C V Jackson; W A Schumacher; S L Kunkel; E M Driscoll; B R Lucchesi
Journal:  Circ Res       Date:  1986-02       Impact factor: 17.367

4.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

Authors:  C A Demopoulos; R N Pinckard; D J Hanahan
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

5.  Effect of platelet-activating factor on coronary circulation of the domestic pig.

Authors:  G Feuerstein; L M Boyd; D Ezra; R E Goldstein
Journal:  Am J Physiol       Date:  1984-03

6.  Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF).

Authors:  D I Cargill; D S Cohen; R G Van Valen; J J Klimek; R P Levin
Journal:  Thromb Haemost       Date:  1983-06-28       Impact factor: 5.249

7.  Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.

Authors:  R Levi; J A Burke; Z G Guo; Y Hattori; C M Hoppens; L M McManus; D J Hanahan; R N Pinckard
Journal:  Circ Res       Date:  1984-02       Impact factor: 17.367

8.  Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig.

Authors:  D Ezra; F R Laurindo; J F Czaja; F Snyder; R E Goldstein; G Feuerstein
Journal:  Prostaglandins       Date:  1987-07

9.  Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs.

Authors:  V B Fiedler; M Mardin; T S Abram
Journal:  Basic Res Cardiol       Date:  1987 Mar-Apr       Impact factor: 17.165

10.  Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.

Authors:  E J Sybertz; R W Watkins; T Baum; K Pula; M Rivelli
Journal:  J Pharmacol Exp Ther       Date:  1985-01       Impact factor: 4.030

View more
  1 in total

1.  Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.

Authors:  W Hu; I K McNicholl; P C Choy; R Y Man
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.